Issued Patents All Time
Showing 1–25 of 90 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12258409 | Method of assessing the efficacy of a test agent for modulating programmed death 1 (PD-1) signaling by using anti-phosphotyrosinylated PD-1 monoclonal antibodies | Vassiliki Boussiotis, Xia Bu, Vikram Juneja, Arlene H. Sharpe, Nikolaos Patsoukis +2 more | 2025-03-25 |
| 12186278 | Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy | Jennifer Brogdon, Hwai Wen Chang, Boris Engels, Gerhard Frey, Jennifer Marie Mataraza +2 more | 2025-01-07 |
| 12139535 | Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents | Yanping Xiao | 2024-11-12 |
| 12103972 | KIR3DL3 as an HHLA2 receptor, anti-HHLA2 antibodies, and uses thereof | Antonio Arulanandam | 2024-10-01 |
| 11827704 | Antibody molecules to PD-1 and uses thereof | Arlene H. Sharpe, Walter A. Blattler, Jennifer Marie Mataraza, Catherine Anne Sabatos-Peyton, Hwai Wen Chang +1 more | 2023-11-28 |
| 11584788 | Compositions and methods for identification, assessment, prevention, and treatment of melanoma using PD-L1 isoforms | F. Stephen Hodi, Jun Zhou, Jingjing Li, Xinqi Wu | 2023-02-21 |
| 11492403 | Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and methods of using thereof | Vassiliki Boussiotis, Xia Bu, Vikram Juneja, Arlene H. Sharpe, Nikolaos Patsoukis +2 more | 2022-11-08 |
| 11485787 | Agents that modulate RGMb-neogenin-BMP signaling and methods of use thereof | Rosemarie Dekruyff, Dale T. Umetsu, Sanhong Yu, Yanping Xiao | 2022-11-01 |
| 11413340 | Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy | Jennifer Brogdon, Hwai Wen Chang, Boris Engels, Gerhard Frey, Jennifer Marie Mataraza +2 more | 2022-08-16 |
| 11359013 | Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway | Arlene H. Sharpe, David M. Dorfman, Rafi Ahmed, Daniel Barber, E. John Wherry | 2022-06-14 |
| 11359020 | Agents that modulate immune cell activation and methods of use thereof | Arlene H. Sharpe, Yanping Xiao, Loise M. Francisco, Rosemarie Dekruyff, Dale T. Umetsu | 2022-06-14 |
| 11261251 | Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor | Rafi Ahmed, Timothy David Jones, Francis Joseph Carr, James P. Gregson | 2022-03-01 |
| 11220545 | Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents | Yanping Xiao | 2022-01-11 |
| 11207393 | Regulatory T cell PD-1 modulation for regulating T cell effector immune responses | Arlene H. Sharpe, Loise M. Francisco, Peter T. Sage, Sun-Jong Lee, Scott B. Lovitch +2 more | 2021-12-28 |
| 11155620 | Method of detecting TIM-3 using antibody molecules to TIM-3 | Catherine Anne Sabatos-Peyton, Barbara Brannetti, Alan S. Harris, Thomas Huber, Thomas Pietzonka +9 more | 2021-10-26 |
| 11124569 | Methods of reducing liver PD-1-expressing CD8+ T cells using PD-1 Fc fusion proteins that bind Fc receptors | Rafi Ahmed, Arlene H. Sharpe, Masao Hashimoto, Hyun T. Jin | 2021-09-21 |
| 11116818 | Compositions and methods for inhibiting viral entry | Hyeryun Choe, Stephanie Jemielity, Dale T. Umetsu, Rosemarie H. De Kruyff | 2021-09-14 |
| 10981990 | Antibody molecules to TIM-3 and uses thereof | Catherine Anne Sabatos-Peyton, Barbara Brannetti, Alan S. Harris, Thomas Huber, Thomas Pietzonka +9 more | 2021-04-20 |
| 10960008 | Methods for treating PTEN deficient epithelial cancers using a combination of anti-PI3KBETA and anti-immune checkpoint agents | Jean Zhao, Johann Bergholz, Thomas M. Roberts | 2021-03-30 |
| 10948492 | PD-L2 biomarkers predictive of PD-1 pathway inhibitor responses in esophagogastric cancers | Adam Bass, Sarah Derks, Scott J. Rodig | 2021-03-16 |
| 10934353 | Single agent anti-PD-L1 and PD-L2 dual binding antibodies and methods of use | Arlene H. Sharpe | 2021-03-02 |
| 10865233 | NKG2D-fc for immunotherapy | Glenn Dranoff, Matthew Vanneman | 2020-12-15 |
| 10851165 | Antibody molecules to PD-L1 and methods of treating cancer | Arlene H. Sharpe, Gerhard Frey, Hwai Wen Chang, Jennifer Marie Mataraza, Glenn Dranoff | 2020-12-01 |
| 10752687 | Antibody molecules to PD-1 and uses thereof | Arlene H. Sharpe, Walter A. Blattler, Jennifer Marie Mataraza, Catherine Anne Sabatos-Peyton, Hwai Wen Chang +1 more | 2020-08-25 |
| 10472419 | Antibody molecules to TIM-3 and uses thereof | Catherine Anne Sabatos-Peyton, Barbara Brannetti, Alan S. Harris, Thomas Huber, Thomas Pietzonka +9 more | 2019-11-12 |